Back to top

Tale of the Tape

Zacks Equity Research

Investors are Betting Against Sangamo Biosciences, Inc. (SGMO) Should You?


Trades from $3
Read Full ArticleHide Full Article
Many investors appear to be quite bearish Sangamo Biosciences, Inc. (SGMO - Free Report) especially if you look at the percentage of the float that is sold short for this stock. Currently, 20.45% of the float is sold short, suggesting an extreme level of bearishness for SGMO.

However, it is worth noting that earnings estimates have actually been moving higher for the company, despite the pessimism. Thanks to these rising estimates, we actually have a Zacks Rank #2 (Buy) on SGMO, so we clearly don’t believe in the negativity surrounding this firm, and are instead looking for shares of SGMO to move higher in the weeks ahead.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Sangamo BioSciences, Inc. (SGMO) - free report >>